Relationships between nitric oxide-mediated endothelial function, eNOS coupling and blood pressure revealed by eNOS-GTP cyclohydrolase 1 double transgenic mice

Experimental Physiology

Volumn 92, Issue 1, 2007, Pages 119-126

  Adlam, D ^a   Bendall, J K ^a   De Bono, J P ^a   Alp, N J ^a   Khoo, J ^a   Nicoli, T ^a   Yokoyama, M ^b   Kawashima, S ^b   Channon, K M ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; NITRIC OXIDE; SUPEROXIDE; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DESENSITIZATION; ENDOTHELIUM; GENE OVEREXPRESSION; GENOTYPE; MOUSE; NONHUMAN; TRANSGENIC MOUSE; VASODILATATION; WILD TYPE;

EID: 33846225546     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2006.035113     Document Type: Article

References (27)

1. Alp NJ, McAteer MA, Khoo J, Choudhury RP & Channon KM (2004). Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 24, 445-450.
2. Alp NJ, Mussa S, Khoo J, Guzik TJ, Cai S, Jefferson A, Rockett KA & Channon KM (2003). Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112, 725-735.
3. Bendall JK, Alp NJ, Warrick N, Cai S, Adlam D, Rockett K, Yokoyama M, Kawashima S & Channon KM (2005). Stoichiometric relationships between endothelial tetrahydrobiopterin, eNOS activity and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS over-expression. Circ Res 97, 864-871.
4. Chataigneau T, Feletou M, Huang PL, Fishman MC, Duhault J & Vanhoutte PM (1999). Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol 126, 219-226.
5. de Bono J, Warrick N, Bendall J, Channon KM & Alp N (2006). Radiochemical HPLC detection of arginine metabolism: Measurement of nitric oxide synthesis and arginase activity in vascular tissue. Nitric Oxide, doi: 10.1016/j.niox.2006.03.008
6. Ding H, Kubes P & Triggle C (2000). Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase. Br J Pharmacol 129, 1194-1200.
7. Furchgott RF & Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376.
8. Heitzer T, Schlinzig T, Krohn K, Meinertz T & Munzel T (2001). Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673-2678.
9. Henry RM, Ferreira I, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Kamp O, Bouter LM & Stehouwer CD (2004). Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study. Atherosclerosis 174, 49-56.
10. Huang A, Sun D, Carroll MA, Jiang H, Smith CJ, Connetta JA, Falck JR, Shesely EG, Koller A & Kaley G (2001). EDHF mediates flow-induced dilation in skeletal muscle arterioles of female eNOS-KO mice. Am J Physiol Heart Circ Physiol 280, H2462-H2469.
11. Huang PL, Huang ZH, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA & Fishman MC (1995). Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239-242.
12. Ignarro LJ (2002). Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 53, 503-514.
13. Kiff RJ, Gardiner SM, Compton AM & Bennett T (1991). Selective impairment of hindquarters vasodilator responses to bradykinin in consciousWistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 103, 1357-1362.
14. Kojda G, Cheng YC, Burchfield J & Harrison DG (2001). Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation 103, 2839-2844.
15. Kojda G, Laursen JB, Ramasamy S, Kent JD, Kurz S, Burchfield J, Shesely EG & Harrison DG (1999). Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. Cardiovasc Res 42, 206-213.
16. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE & Harrison DG (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111, 1201-1209.
17. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T & Harrison DG (2001). Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103, 1282-1288.
18. Ohashi Y, Kawashima S, Hirata K, Yamashita T, Ishida T, Inoue N, Sakoda T, Kurihara H, Yazaki Y & Yokoyama M (1998). Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 102, 2061-2071.
19. Panza JA, García CE, Kilcoyne CM, Quyyumi AA & Cannon RO III (1995). Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91, 1732-1738.
20. Popp R, Fleming I & Busse R (1998). Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance. Circ Res 82, 696-703.
21. Scotland RS, Chauhan S, Vallance PJ & Ahluwalia A (2001). An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide. Hypertension 38, 833-839.
22. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC & Smithies O (1996). Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 93, 13176-13181.
23. Sun D, Huang A, Smith CJ, Stackpole CJ, Connetta JA, Shesely EG, Koller A & Kaley G (1999). Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice. Circ Res 85, 288-293.
24. van Haperen R, de Waard M, van Deel E, Mees B, Kutryk M, van Aken T, Hamming J, Grosveld F, Duncker DJ & de Crom R (2002). Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide. J Biol Chem 277, 48803-48807.
25. Vasquez-Vivar J, Kalyanaraman B & Martasek P (2003). The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic Res 37, 121-127.
26. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N & Masters BS, Karoui H, Tordo P & Pritchard KA Jr (1998). Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 95, 9220-9225.
27. Vasquez-Vivar J, Martasek P & Kalyanaraman B (2004). Superoxide generation from nitric oxide synthase: role of cofactors and protein interaction. In Biological Magnetic Resonance, ed. Eaton SS, Eaton GR & Berliner LS, pp. 75-91. Kluger Academic Publishers, Amsterdam.